[Other] Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial |
Reward40points
Best Answer
3 day(s) ago
|
| |
| |
20
Synergistic Effect of the Photothermal Performance and Osteogenic Properties of MXene and Hydroxyapatite Nanoparticle Composite Nanofibers for Osteogenic Application
10
Machine learning aided near-field acoustic holography based on equivalent source method
20
Formulation Development and Characterization of Rapid Mouth Dissolving Film of Frovatriptan Succinate
10
Preparation, characterization and catalytic performance of high stability of LaCoO3@CuO composite with core-shell structure for methanol steam reforming
10
https://link.springer.com/article/10.1007/s40435-023-01144-2
